Reproducibility of 3.0 Tesla Magnetic Resonance Spectroscopy for Measuring Hepatic Fat Content

被引:60
作者
van Werven, Jochem R. [1 ]
Hoogduin, Johannes M. [2 ,3 ]
Nederveen, Aart J. [1 ]
van Vliet, Andre A. [4 ]
Wajs, Ewa [5 ]
Vandenberk, Petra [5 ]
Stroes, Erik S. G. [6 ]
Stoker, Jaap [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands
[3] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, NL-9713 AV Groningen, Netherlands
[4] PRA Int, Zuidlaren, Netherlands
[5] Johnson & Johnson Pharmaceut Res & Dev, Beerse, Belgium
[6] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands
关键词
reproducibility; MR spectroscopy; fatty liver; NONINVASIVE ASSESSMENT; TRIGLYCERIDE CONTENT; MR SPECTROSCOPY; LIVER-BIOPSY; IN-VIVO; QUANTIFICATION; STEATOSIS; ISSUES;
D O I
10.1002/jmri.21837
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To investigate reproducibility of proton magnetic resonance spectroscopy (H-1-MRS) to measure hepatic triglyceride content (HTGC). Materials and Methods: In 24 subjects, HTGC was evaluated using H-1-MRS at 3.0 Tesla. We studied "between-weeks" reproducibility and reproducibility of H-1-MRS in subjects with fatty liver. We also studied within liver variability and within day reproducibility. Reproducibility was assessed by coefficient of variation (CV), repeatability coefficient (RC), and intraclass correlation coefficient (ICC). Results: The CV of between weeks reproducibility was 9.5%, with a RC of 1.3% HTGC (ICC 0.998). The CV in fatty livers was 4.1%, with a RC of 1.3% HTGC (ICC 0.997). Within day CV was 4.5%, with a RC of 0.4% HTGC (ICC 0.999). CV for within liver variability was 14.5%. Conclusion: Reproducibility of H-1-MRS to measure HTGC for "between-weeks" measurements and in fatty livers is high, which is important for follow-up studies. Within liver variability displays a larger variation, meaning that liver fat is not equally distributed and during consecutive measurements the same voxel position should be used.
引用
收藏
页码:444 / 448
页数:5
相关论文
共 29 条
[1]   Nonalcoholic fatty liver disease [J].
Brunt, Elizabeth M. ;
Wong, Vincent W. -S. ;
Nobili, Valerio ;
Day, Christopher P. ;
Sookoian, Silvia ;
Maher, Jacquelyn J. ;
Bugianesi, Elisabetta ;
Sirlin, Claude B. ;
Neuschwander-Tetri, BrentA. ;
Rinella, Mary E. .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[2]   A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[3]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]   Fatty Liver Disease: MR Imaging Techniques for the Detection and Quantification of Liver Steatosis [J].
Cassidy, Fiona Hughes ;
Yokoo, Takeshi ;
Aganovic, Lejla ;
Hanna, Robert F. ;
Bydder, Mark ;
Middleton, Michael S. ;
Hamilton, Gavin ;
Chavez, Alyssa D. ;
Schwimmer, Jeffrey B. ;
Sirlin, Claude B. .
RADIOGRAPHICS, 2009, 29 (01) :231-260
[5]   MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: Preliminary results [J].
de Bazelaire, CMJ ;
Duhamel, GD ;
Rofsky, NM ;
Alsop, DC .
RADIOLOGY, 2004, 230 (03) :652-659
[6]   Quantitative proton magnetic resonance spectroscopy of the normal liver and malignant hepatic lesions at 3.0 Tesla [J].
Fischbach, F. ;
Schirmer, T. ;
Thormann, M. ;
Freund, T. ;
Ricke, J. ;
Bruhn, H. .
EUROPEAN RADIOLOGY, 2008, 18 (11) :2549-2558
[7]   Hepatic MRI for fat quantitation - Its relationship to fat morphology, diagnosis, and ultrasound [J].
Fishbein, M ;
Castro, F ;
Cheruku, S ;
Jain, S ;
Webb, B ;
Gleason, T ;
Stevens, WR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (07) :619-625
[8]  
Grundy SM, 2004, CIRCULATION, V109, P433, DOI [10.1161/01.CIR.0000111245.75752.C6, 10.1161/01.CIR.0000112379.88385.67]
[9]   Liver fat content measured by magnetic resonance spectroscopy at 3.0 Tesla independently correlates with plasminogen activator inhibitor-1 and body mass index in type 2 diabetic subjects [J].
Ishii, M ;
Yoshioka, Y ;
Ishida, W ;
Kaneko, Y ;
Fujiwara, F ;
Taneichi, H ;
Miura, M ;
Toshihiro, M ;
Takebe, N ;
Iwai, M ;
Suzuki, K ;
Satoh, J .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 206 (01) :23-30
[10]   Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT [J].
Jacobs, JE ;
Birnbaum, BA ;
Shapiro, MA ;
Langlotz, CP ;
Slosman, F ;
Rubesin, SE ;
Horii, SC .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1998, 171 (03) :659-664